Bausch Health Companies (BHC) Revenue (2009 - 2026)
Bausch Health Companies (BHC) posted Revenue of $2.9 billion for Q2 2026, up 13.0% sequentially from $2.5 billion in Q1 2026, and up 12.73% YoY from $2.5 billion in Q2 2025.
Bausch Health Companies (BHC) Revenue (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Revenue for 18 years, with the latest figure at $2.9 billion in Q2 2026.
- Quarterly Revenue rose 12.73% year-over-year to $2.9 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $10.9 billion (up 10.09% YoY) and the FY2025 annual result came in at $10.3 billion, up 6.66% from the prior year.
- Revenue rose to $2.9 billion in Q2 2026 per BHC's latest filing, from $2.5 billion in the prior quarter.
- Over five years, Revenue peaked at $2.9 billion in Q2 2026 and troughed at $1.9 billion in Q1 2022.
- A 5-year average of $2.3 billion and a median of $2.3 billion in 2024 frame the typical range for Revenue.
- The sharpest annual moves came in 2022 and 2026: Revenue plunged 69.71% in 2022, then advanced 12.73% in 2026.
- Over 5 years, Revenue stood at $2.2 billion in 2022, then gained by 9.8% to $2.4 billion in 2023, then gained by 6.27% to $2.6 billion in 2024, then rose by 9.26% to $2.8 billion in 2025, then rose by 2.0% to $2.9 billion in 2026.
- According to Business Quant data, Revenue over the past three periods registered $2.9 billion, $2.5 billion, and $2.8 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Bausch Health Companies | 2.55 Bn | 712.00 Mn | 2.10 Bn | 2.85 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.85 Bn |
| Mar 31, 2026 | 2.52 Bn |
| Dec 31, 2025 | 2.80 Bn |
| Sep 30, 2025 | 2.68 Bn |
| Jun 30, 2025 | 2.53 Bn |
| Mar 31, 2025 | 2.26 Bn |
| Dec 31, 2024 | 2.56 Bn |
| Sep 30, 2024 | 2.51 Bn |
| Jun 30, 2024 | 2.40 Bn |
| Mar 31, 2024 | 2.15 Bn |
| Dec 31, 2023 | 2.41 Bn |
| Sep 30, 2023 | 2.24 Bn |
| Jun 30, 2023 | 2.17 Bn |
| Mar 31, 2023 | 1.94 Bn |
| Dec 31, 2022 | 2.19 Bn |
| Sep 30, 2022 | 2.05 Bn |
| Jun 30, 2022 | 1.97 Bn |
| Mar 31, 2022 | 1.92 Bn |
| Dec 31, 2021 | 7.24 Bn |
| Sep 30, 2021 | 2.11 Bn |